Why is Sanofi India falling/rising?

As of 08-Aug, Sanofi India Ltd's stock price is currently at 5,219.00, reflecting an increase of 27.8, or 0.54%. The stock has shown a trend reversal by gaining after two consecutive days of decline, and it has outperformed its sector by 1.7% today. However, despite this uptick, the stock is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 5.99%, and it has experienced a significant drop of 14.44% year-to-date, indicating a challenging performance compared to the benchmark Sensex, which has gained 2.20% in the same period. Positive factors contributing to the stock's movement include high management efficiency with a return on equity of 35.83%, a low debt-to-equity ratio, and strong recent financial results, which may bolster investor confidence.
In the broader market context, Sanofi India's short-term performance has been notably weaker than the benchmark, as evidenced by its 1-week decline compared to the Sensex's smaller drop of 0.92%. This underperformance over various time frames, including a 20.67% decline over the past year versus the Sensex's 1.23% gain, highlights the stock's struggles in the current market environment. Despite the recent positive price movement, the overall trend indicates that the stock has faced significant challenges, and the high institutional holdings suggest that informed investors are closely monitoring its fundamentals, which may influence future price movements.